BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29925915)

  • 1. A Randomized Controlled Trial of Opt-in Versus Opt-Out Colorectal Cancer Screening Outreach.
    Mehta SJ; Khan T; Guerra C; Reitz C; McAuliffe T; Volpp KG; Asch DA; Doubeni CA
    Am J Gastroenterol; 2018 Dec; 113(12):1848-1854. PubMed ID: 29925915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Patient Portal Messaging Before Mailing Fecal Immunochemical Test Kit on Colorectal Cancer Screening Rates: A Randomized Clinical Trial.
    Goshgarian G; Sorourdi C; May FP; Vangala S; Meshkat S; Roh L; Han MA; Croymans DM
    JAMA Netw Open; 2022 Feb; 5(2):e2146863. PubMed ID: 35119462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Text Messaging and Opt-out Mailed Outreach in Colorectal Cancer Screening: a Randomized Clinical Trial.
    Huf SW; Asch DA; Volpp KG; Reitz C; Mehta SJ
    J Gen Intern Med; 2021 Jul; 36(7):1958-1964. PubMed ID: 33511567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Refined Messaging for a Mailed Colorectal Cancer Screening Program: Findings from the PROMPT Study.
    Coronado GD; Thompson JH; Petrik AF; Nyongesa DB; Leo MC; Castillo M; Younger B; Escaron A; Chen A
    J Am Board Fam Med; 2019; 32(3):318-328. PubMed ID: 31068396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
    Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
    Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Colorectal Neoplasia in a Cohort Before and After the Change of Fecal Occult Blood Test in a French Colorectal Cancer Screening Program.
    Koïvogui A; Mab GL; Benamouzig R
    Am J Gastroenterol; 2018 Dec; 113(12):1891-1899. PubMed ID: 30337703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Randomized Controlled Trial Testing Provision of Fecal and Blood Test Options on Participation for Colorectal Cancer Screening.
    Symonds EL; Hughes D; Flight I; Woodman R; Chen G; Ratcliffe J; Pedersen SK; Fraser RJL; Wilson CJ; Young GP
    Cancer Prev Res (Phila); 2019 Sep; 12(9):631-640. PubMed ID: 31266825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention-sponsored Summit.
    Gupta S; Coronado GD; Argenbright K; Brenner AT; Castañeda SF; Dominitz JA; Green B; Issaka RB; Levin TR; Reuland DS; Richardson LC; Robertson DJ; Singal AG; Pignone M
    CA Cancer J Clin; 2020 Jul; 70(4):283-298. PubMed ID: 32583884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Financial Incentives on Patient Use of Mailed Colorectal Cancer Screening Tests: A Randomized Clinical Trial.
    Mehta SJ; Pepe RS; Gabler NB; Kanneganti M; Reitz C; Saia C; Teel J; Asch DA; Volpp KG; Doubeni CA
    JAMA Netw Open; 2019 Mar; 2(3):e191156. PubMed ID: 30901053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screen to Save: Results from NCI's Colorectal Cancer Outreach and Screening Initiative to Promote Awareness and Knowledge of Colorectal Cancer in Racial/Ethnic and Rural Populations.
    Whitaker DE; Snyder FR; San Miguel-Majors SL; Bailey LO; Springfield SA
    Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):910-917. PubMed ID: 32358038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Sequential or Active Choice for Colorectal Cancer Screening Outreach: A Randomized Clinical Trial.
    Mehta SJ; Induru V; Santos D; Reitz C; McAuliffe T; Orellana C; Volpp KG; Asch DA; Doubeni CA
    JAMA Netw Open; 2019 Aug; 2(8):e1910305. PubMed ID: 31469393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral interventions to improve population health outreach for hepatitis C screening: randomized clinical trial.
    Mehta SJ; Day SC; Norris AH; Sung J; Reitz C; Wollack C; Snider CK; Shaw PA; Asch DA
    BMJ; 2021 May; 373():n1022. PubMed ID: 34006604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Colorectal Cancer Screening Participation in Southern Khorasan (Iran).
    Ramazani AA; Norozi E; AmirabadiZadeh H; Ehteshampour AR; Salehiniya H
    J Gastrointest Cancer; 2021 Mar; 52(1):187-191. PubMed ID: 32125621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Rescue" of Nonparticipants in Colorectal Cancer Screening: A Randomized Controlled Trial of Three Noninvasive Test Options.
    Young GP; Chen G; Wilson CJ; McGrane E; Hughes-Barton DL; Flight IHK; Symonds EL
    Cancer Prev Res (Phila); 2021 Aug; 14(8):803-810. PubMed ID: 34127509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
    Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
    Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for delivery of faecal occult blood test kits and participation to colorectal cancer screening in the Emilia-Romagna Region of Italy.
    Mancini S; Ravaioli A; Falcini F; Giuliani O; Corradini R; De Girolamo G; Goldoni CA; Finarelli AC; Naldoni C; Landi P; Sassoli de Bianchi P; Bucchi L
    Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 28032381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial.
    Coronado GD; Petrik AF; Vollmer WM; Taplin SH; Keast EM; Fields S; Green BB
    JAMA Intern Med; 2018 Sep; 178(9):1174-1181. PubMed ID: 30083752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of false-positive results for future cancer screenings.
    Taksler GB; Keating NL; Rothberg MB
    Cancer; 2018 Jun; 124(11):2390-2398. PubMed ID: 29682740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opting out increases HIV testing in a large sexually transmitted infections outpatient clinic.
    Heijman RL; Stolte IG; Thiesbrummel HF; van Leent E; Coutinho RA; Fennema JS; Prins M
    Sex Transm Infect; 2009 Aug; 85(4):249-55. PubMed ID: 19103642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.